Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: Neurosci Biobehav Rev. 2013 Nov 6;38:1–16. doi: 10.1016/j.neubiorev.2013.10.013

Table 1.

Factors modulating drug cue-elicited activation in brain regions most commonly observed in cue-reactivity studies.

Brain
region
Length/intensity
of usea and
addiction
severityb
Current treatment
statusc and/or drug
availability/expectancyd
Abstinencee
and/or withdrawal
symptomsf
Sensory
Modality
of cuesg
Length of
presentationh
Explicit
regulationi
Stressor
exposurej
coc tob alc coc tob alc coc tob alc coc tob alc coc tob alc coc tob alc coc tob alc
ACC + + + + +/−
AMY +
CER +/−
DLPFC + + + + +
DS + + + + + +
FG/VC +/− + + +
HIPP/PH +/− + +
IFG +/− +
INS +/− + + + +
IPC/SPC +/− + +
MC +/− + + + + +
MPFC + + +
OFC + + + +/− +
PCC + + + + + + + +
PMC +/− +
SC +
SMA +
SN +
THAL + +
VLPFC +
VS/NAc + +/− + +
VTA + +

The signs “+” and “-” indicate greater or weaker cue-induced responses, respectively for:

a

heavier use vs. lighter use

b

higher addiction severity vs. lower addiction severity

c

current users not seeking treatment vs. treatment seekers, and/or dcurrent non-treatment seekers expecting drug availability vs. not expecting drug availability

e

longer abstinence vs. shorter/no abstinence and/or

f

more severe withdrawal vs. less severe withdrawal

g

multisensory or haptic cues vs. visual-only cues

h

longer cue presentation vs. shorter cue presentation

i

subjects explicitly regulating their drug urges vs. no explicit regulation

j

stressor exposure vs. absence of stressors. For more information on the factors “craving” and “treatment outcome” (more difficult to manipulate and control for) and “implicit regulation” (no evidence for directly comparing implicit regulation vs. no regulation), please refer to the text.